Efficacy and Safety of Ixekizumab in Patients with Refractory Guttate Psoriasis
Clinical trial NCT06374979 · UNKNOWN
Trial details
- NCT number
- NCT06374979
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2025-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.